Last update:

Cardiology news

Red blood cell changes may explain link between long-term diabetes and vascular damage

The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important ...

What is CPR and who needs it?

Cardiopulmonary resuscitation (CPR) is a vital skill anyone can perform. It is administered to an unconscious person who is not breathing normally.

Heart condition? The psychologist will see you now

The link between heart disease and mental health conditions such as anxiety, depression, and post-traumatic stress disorder (PTSD) is becoming so clear that some cardiology practices are offering psychological support as ...

How does sleep help rewind the body's clock?

A night-shift worker finishes at dawn. Their phone says Tuesday, but their body feels like it's Monday. The body's internal clock, or circadian rhythm, controls physiological processes such as sleeping, eating and physical ...

Cardiac arrest vs. heart attacks: Who is at risk?

Sudden cardiac arrest may occur in various conditions when someone, while active (playing basketball or walking with friends), collapses and passes out. Their blood pressure drops, and often their heart stops. This may be ...

Uterine fibroids linked to elevated heart disease risk

Long-term heart disease risk in women diagnosed with uterine fibroids was more than 80% higher than in women without fibroids, according to new independent research published in the Journal of the American Heart Association.

New AI tool improves heart test evaluation

A new AI tool can rapidly evaluate data from echocardiography, an imaging test commonly used to diagnose heart disease, according to new research led by Cedars-Sinai. The study, published in JACC, found the tool could speed ...

GLP-1RAs shown to reduce risk of cardiovascular death

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials ...